Skip to main content
. 2017 May 24;28(7):677–701. doi: 10.1097/CAD.0000000000000513

Table 5.

Summary of the totality of clinical pharmacology data for the 11 drugs that did not perform a new drug application or postmarketing renal impairment study

graphic file with name cad-28-677-g006.jpg